Author

V. Detours

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 4 Research Focus:differential expression· 3 Approach:experimental assay· 3 Organism:human· 3 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell-cell communication· 1 Research Focus:clustering· 1

Frequent Co-Authors

A. Tourneur· 2 shared C. Maenhaut· 2 shared D. Larsimont· 2 shared L. Craciun· 2 shared M. Romitti· 2 shared M. Tarabichi· 2 shared S. Costagliola· 2 shared A. A. Schiavo· 1 shared

Activity by Year

2017-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. Tourneur

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Favorable histo-molecular remodeling of pancreatic ductal adenocarcinoma after Total Neoadjuvant Therapy including Stereotactic Body Radiotherapy

C. Bouchart, O. A. Senar, J. Navez, L. Verset, A. Boisson, M. Hein, K. Stosic, E. Quertinmont, V. Tafciu, S. Zhao, L. Mas, N. D'Haene, D. Van Gestel, L. Moretti, I. Rooman, , J.-L. Van Laethem

This study shows that combining FOLFIRINOX with stereotactic body radiotherapy remodels pancreatic ductal adenocarcinoma, improving stromal and metabolic features and prognosis.

bioRxiv · Apr 30, 2024 · PreprintCancer Biology

Idiosyncratic and generic single nuclei and spatial transcriptional patterns in papillary and anaplastic thyroid cancers

A. Tourneur, J. Rodrigues Vitoria, M. Saiselet, L. Craciun, D. Larsimont, A. Lefort, F. Libert, C. Maenhaut, S. Costagliola, M. Tarabichi, M. Romitti, V. Detours

This study uses single nuclei RNA-seq and spatial transcriptomics to analyze transcriptional patterns in papillary and anaplastic thyroid cancers, revealing idiosyncratic and generic transcriptional variations and EMT-related features.

bioRxiv · Feb 15, 2024 · PreprintCancer Biology

Dual targeting of MAPK and PI3K pathways unlocks redifferentiation of Braf-mutated thyroid cancer organoids

H. Lasolle, A. A. Schiavo, A. Tourneur, P. Gillotay, B. d. F. da Fonseca, L. Ceolin, O. Monestier, B. Aganahi, L. Chomette, M. M. L. Kizys, L. Haenebalcke, T. Pieters, S. Goossens, J. Haigh, V. Detours, , M. Romitti

This study uses thyroid organoids to show that combining MAPK and PI3K inhibitors can reverse dedifferentiation in Braf-mutated thyroid cancer cells.

bioRxiv · Mar 30, 2023 · PreprintCancer Biology

Distinctive desmoplastic 3D morphology associated with BRAFV600E in papillary thyroid cancers

M. Tarabichi, A. Antoniou, S. Le Pennec, D. Gacquer, N. de Saint Aubain, L. Craciun, T. Cielen, I. Laios, D. Larsimont, G. Andry, J. E. Dumont, C. Maenhaut, V. Detours

The paper describes a distinctive 3D morphology in BRAFV600E-mutated papillary thyroid cancers where tumor cells form a sparse mesh within a proliferative stroma, challenging traditional tumor growth models.

bioRxiv · Jul 6, 2017Cancer Biology